RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells
American Journal of Physiology-Cell Physiology · 2023
DOI: 10.1152/ajpcell.00494.2022 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2023. Verfasst von Wan-Ling Liao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
This study represents a pioneering endeavor in comprehending the intricate interplay between RAGE and EGFR signaling within NSCLC. The findings reveal that RAGE serves to enhance EGFR phosphorylation and activation, consequently modulating apoptosis regulators through the EGFR-STAT3 and EGFR-Erk1/2 signaling pathways. Through this mechanism, RAGE potentially imparts resistance to the toxicity induced by EGFR-TKIs in NSCLC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
- Department of Medical Research, Translational Cell Therapy Center, China Medical University Hospital, Taichung, Taiwan.
- Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
ORCID-Profile: Ho Lin, Mei-Chih Chen
Förderung
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Liao, W. L., Lin, H., Li, Y. H., Yang, T. Y., & Chen, M. C. (2023). RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00494.2022
Vancouver
Liao WL, Lin H, Li YH, Yang TY, Chen MC. RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells. American Journal of Physiology-Cell Physiology. 2023. doi:10.1152/ajpcell.00494.2022
BibTeX
@article{Liao2023,
author = {Liao, Wan-Ling and Lin, Ho and Li, Yu-Hsuan and Yang, Tsung-Ying and Chen, Mei-Chih},
title = {RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells},
journal = {American Journal of Physiology-Cell Physiology},
year = {2023},
doi = {10.1152/ajpcell.00494.2022}
}
EUVIMED